- Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells2016 | First Faculty of Medicine
- Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies2022 | First Faculty of Medicine
- Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells2020 | First Faculty of Medicine, Faculty of Science
- Immunotherapy using CAR T-cells2015 | Faculty of Medicine in Pilsen
- Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells2021 | Central Library of Charles University, Faculty of Science
- CAR-T treatment in oncology CAR-T treatment in onkology and hematooncology2019 | Publication without faculty affiliation
- Cellular therapy with axicabtagene ciloleucel2021 | Publication without faculty affiliation
- Yescarta - new hope for patients with relapsed diffuse large-cell lymphoma?2019 | First Faculty of Medicine
- Trial Watch: Adoptive cell transfer for oncological indications2015 | Second Faculty of Medicine
- Current use of CAR cells in lymphoma therapy2022 | First Faculty of Medicine
- Immunotherapy Approaches in Cancer Treatment2015 | First Faculty of Medicine
- CAR T cell therapy in lymphoma treatment2018 | First Faculty of Medicine
- Multiple myeloma - are we in 2020 able to cure the patient?2020 | First Faculty of Medicine
- Immunotherapy in the lymphoma treatment2020 | First Faculty of Medicine
- Allogeneic hematopoietic cell transplantation and cellular therapy in CLL2019 | First Faculty of Medicine
- CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment2017 | Second Faculty of Medicine
- Novel therapeutic approaches in the treatment of solitary fibrous tumors: A call for a combination therapy2020 | First Faculty of Medicine, Second Faculty of Medicine
- Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting2018 | Faculty of Medicine in Pilsen
- New trends in the multiple myeloma treatment2019 | First Faculty of Medicine
- Current Immunotherapy Approaches in Non-Hodgkin Lymphomas2020 | First Faculty of Medicine
- Emerging glyco-based strategies to steer immune responses2021 | Faculty of Science
- A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-212018 | First Faculty of Medicine, Central Library of Charles University
- Mantle cell lymphoma: insights into therapeutic targets at the preclinical level2020 | First Faculty of Medicine
- Natural killer cell-based strategies for immunotherapy of cancer2022 | Faculty of Science
- The Role of Cryopreservation Techniques in Manufacturing, Transport, and Storage of Car-T Therapy Products2023 | Faculty of Medicine in Hradec Králové
- A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)2021 | Second Faculty of Medicine
- Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma2022 | First Faculty of Medicine
- Gastrointestinal toxicity of systemic oncology immunotherapy2022 | First Faculty of Medicine, Central Library of Charles University
- CAR-T THERAPY, THE NEW AND GROWING APPLICATION OF CRYOTECHNOLOGY IN MEDICINE2023 | Publication without faculty affiliation